PDS Biotechnology Corporation

(NASDAQ:PDSB)

Latest On PDS Biotechnology Corporation (PDSB):

Date/Time Type Description Signal Details
2023-05-27 05:27 ESTNewsPDS Biotechnology: Promising Interim HNSCC Data Reaffirms Investment ProspectsN/A
2023-05-26 15:12 ESTNewsPDS Biotech gains 20% after Phase 2 data for lead asset in head and neck cancerN/A
2023-05-15 13:46 ESTNewsPDS Biotechnology GAAP EPS of -$0.32 misses by $0.01N/A
2023-05-15 13:45 ESTNewsPDS Biotechnology Corporation (PDSB) Q1 2023 Earnings Call TranscriptN/A
2023-04-26 20:58 ESTNewsPDS Biotechnology: Late-Stage Biotech With Enormous PotentialN/A
2023-04-05 10:59 ESTNewsPDS Biotechnology's PDS0101 Shows Potential In HPV-Positive Head And Neck CancersN/A
2023-03-29 01:52 ESTNewsPDS Biotechnology Corporation (PDSB) Q4 2022 Earnings Call TranscriptN/A
2023-03-28 10:25 ESTNewsPDS Biotechnology GAAP EPS of -$1.43 misses by $0.35N/A
2023-03-27 19:17 ESTNewsPDS Biotechnology Q4 2022 Earnings PreviewN/A
2023-01-08 19:28 ESTNewsPDS Biotechnology: Good Data, But I Am A Little Perplexed By Their FinancesN/A
2023-01-03 19:36 ESTNewsMerck KGaA to license potential tumor drug to PDS in cash, stock transactionN/A
2023-01-03 19:36 ESTNewsPDS Biotechnology slips 14% following German Merck licensing dealN/A
2022-12-28 16:32 ESTNewsPDS Biotechnology up 3% after reporting data on triple combination for HPV cancersN/A
2022-11-14 13:34 ESTNewsPDS Biotechnology GAAP EPS of -$0.26 beats by $0.02N/A
2022-11-14 13:33 ESTNewsPDS Biotech surges 22% as drug shows response in cervical cancer patients in phase 2 trialN/A
2022-11-14 13:32 ESTNewsPDS Biotechnology Corporation (PDSB) Q3 2022 Earnings Call TranscriptN/A
2022-11-11 15:16 ESTNewsPDS Biotechnology Q3 2022 Earnings PreviewN/A
2022-10-24 11:18 ESTNewsPDS Biotech: Strong Data Indicate Further UpsideN/A
2022-10-11 19:21 ESTNewsPDS Biotech stock soars 14% as PDS0101 shows promise vs HPV-positive cancers in interim trial dataN/A
2022-10-04 20:14 ESTNewsPDS Biotechnology: Better Than A 3 Buck Dart ThrowN/A
2022-10-03 15:05 ESTNewsPDS Biotech jumps 13% as FDA clears further development of lead assetN/A
2022-08-25 00:57 ESTNewsPDS Biotechnology files for $150 mixed shelf offeringN/A
2022-08-09 06:36 ESTNewsPDS Biotechnology GAAP EPS of -$0.20 beats by $0.08N/A
2022-08-09 06:36 ESTNewsPDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 15:23 ESTNewsPDS Biotech spikes as panel backs continuation of cancer trial for lead assetN/A
2022-06-02 13:18 ESTNewsPDS Biotech wins FDA Fast Track status for head and neck cancer therapyN/A
2022-06-01 03:27 ESTNewsPDS Biotech gets UK drug regulator nod to start trial of PDS0101/Keytruda comboN/A
2022-05-28 00:48 ESTNewsPDS Biotech triple combo cancer therapy shows promise in ongoing mid-stage studyN/A
2022-05-28 00:48 ESTNewsPDS Biotechnology: Speculative Biotech Worth Buying After Latest DataN/A
2022-05-12 03:29 ESTNewsPDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 07:53 ESTNewsPDS Biotechnology GAAP EPS of -$0.32 misses by $0.09N/A
2022-04-20 02:35 ESTNewsPDS Biotech raises $1.2M via sale of net operating loss tax benefits under New Jersey programN/A
2022-03-31 15:45 ESTNewsPDS Biotechnology GAAP EPS of -$0.66 beats by $0.05N/A
2022-03-31 15:45 ESTNewsPDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-30 22:31 ESTNewsPDS Biotechnology Q4 2021 Earnings PreviewN/A
2022-03-23 10:04 ESTNewsPDS Biotechnology FY 2021 Earnings PreviewN/A
2022-03-16 08:46 ESTNewsPDS Biotech reaches an enrollment target for mid-stage cancer trial for lead assetN/A
2022-02-24 17:18 ESTNewsPDS Biotech posts early safety data for PDS0101, Keytruda combo in head and neck cancerN/A
2022-02-22 09:08 ESTNewsPDS Biotechnology: Versamune Platform Targeting HPV-Associated CancersN/A
2022-02-02 23:13 ESTNewsPDS Biotech to further advance mid-stage trial for head and neck cancer after early winN/A
2022-01-27 19:02 ESTNewsPDS Biotech universal influenza vaccine shows efficacy in preclinical studiesN/A
2021-11-10 13:59 ESTNewsPDS Biotechnology EPS misses by $0.04N/A
2021-11-10 13:58 ESTNewsPDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 13:58 ESTNewsPDS Biotechnology Corporation 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-09 14:52 ESTNewsPDS Biotechnology Q3 2021 Earnings PreviewN/A
2021-11-08 17:06 ESTNewsPDS Biotechnology inks licensing agreement with National Cancer InstituteN/A
2021-11-02 02:09 ESTNewsPDS Biotech to license antigens from University of Georgia for universal flu vaccineN/A
2021-10-21 14:14 ESTNewsPDS Biotechnology suspends enrollment in HPV cancer trialN/A
2021-10-06 15:02 ESTNewsPDS Biotechnology appoints new CFON/A
2021-09-22 03:28 ESTNewsPDS Biotech: Looking Attractive Despite 52-Week High PriceN/A

About PDS Biotechnology Corporation (PDSB):

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial, a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104 (TRP2) for the treatment of melanoma. The company has a collaboration agreement with Merck & Co. to combine PDS0101 with Keytruda, a checkpoint inhibitor to treat human papillomavirus positive recurrent or metastatic head and neck cancer; and an agreement with Farmacore Biotechnology for the development of Versamune-based vaccine to prevent COVID-19 infection. The company is based in Princeton, New Jersey.

PDSB Quotes by TradingView

See Advanced Chart

General

  • Name PDS Biotechnology Corporation
  • Symbol PDSB
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 13
  • Last Split Factor1:20
  • Last Split Date2019-03-18
  • Fiscal Year EndDecember
  • IPO Date2015-10-01
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.pdsbiotech.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 3.78
  • Enterprise Value EBITDA 0.15
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.19
  • Return on Assets -32%
  • Return on Equity -64%
  • Earnings Per Share $0.12
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 114.42 million
  • EBITDA -10733040
  • Analyst Target Price $6.62
  • Book Value Per Share $1.39
View More

Share Statistics

  • Shares Outstanding 22.26 million
  • Shares Float 17.17 million
  • % Held by Insiders 2761%
  • % Held by Institutions 14.81%
  • Shares Short 470309
  • Shares Short Prior Month 338882
  • Short Ratio 0.29
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • 52 Week High $6.35
  • 52 Week Low $0.62
  • 50 Day Moving Average 4.48
  • 200 Day Moving Average 2.86
View More

Dividends

  • Dividend Date 2019-03-18
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

PDS Biotechnology Corporation (PDSB) Dividend Calendar:

PDSB's last dividend payment was made to shareholders on March 18, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

PDS Biotechnology Corporation (PDSB) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-11$N/A-$0.23-$0.14-64.29%
2020-06-302020-08-13$N/A-$0.19-$0.2317.39%
2020-03-312020-05-13$N/A-$0.39-$0.15-160%
2019-12-312020-03-27$N/A-$0.84-$1.0016%
2019-09-302019-11-07$N/A-$0.92-$0.82-11.71%
2019-06-302019-08-01$N/A-$0.75
2019-03-312019-05-14$N/A$1.47
2018-12-312019-02-21$N/A-$1.96
2018-09-302018-11-01$N/A-$2.72
2018-06-302018-08-01-$8.20-$10.5222.05%
2018-03-312018-05-01$N/A-$13.40-$10.52-27.38%
2017-12-312018-03-01$N/A-$9.00-$8.62-4.41%
2017-09-302017-11-01$N/A-$7.40-$9.5522.51%
2017-06-302017-08-01-$8.80-$8.74-0.69%
2017-03-312017-05-03-$8.40-$8.450.59%
2016-12-312017-03-02-$0.33-$0.4221.43%
2016-09-302016-11-01-$0.37-$0.407.5%
2016-06-302016-08-03-$0.33-$0.3710.81%
2016-03-312016-05-03-$0.32-$0.345.88%
2015-12-312016-03-08-$0.30-$0.313.23%
2015-09-302015-10-06-$7.08-$1.59-345.28%

PDS Biotechnology Corporation (PDSB) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

PDS Biotechnology Corporation (PDSB) Chart:

PDS Biotechnology Corporation (PDSB) News:

Below you will find a list of latest news for PDS Biotechnology Corporation (PDSB) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

PDS Biotechnology Corporation (PDSB) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.6CALL12 813121.08TRUE0.60
2024-05-1750.1CALL260 1607165.42FALSE0.061.5
2024-05-177.50.05CALL13 605204.25FALSE0.050
2024-05-17100.03CALL0 10820FALSE00
2024-05-1712.50.05CALL0 3310FALSE00
2024-05-172.50.25PUT0 237143.4FALSE00
2024-05-1751.6PUT0 361160.11TRUE00
2024-05-177.50PUT0 0315.78TRUE00
2024-05-17106.2PUT0 0265.33TRUE00
2024-05-1712.50PUT0 0224.87TRUE00
2024-06-212.50CALL0 0807.75TRUE00
2024-06-2150CALL0 00FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 0548.8FALSE00
2024-06-2150PUT0 0181.78TRUE00
2024-06-217.50PUT0 0743.31TRUE00
2024-08-162.50.8CALL0 487335.69TRUE00
2024-08-1650.2CALL0 792125.39FALSE00
2024-08-167.50.17CALL0 3860FALSE00
2024-08-16100.15CALL0 3430FALSE00
2024-08-1612.50.13CALL5 455161.92FALSE0.130
2024-08-162.50.4PUT0 262121.01FALSE00
2024-08-1652.21PUT0 398123.91TRUE00
2024-08-167.53.8PUT0 100144.13TRUE00
2024-08-16104.9PUT0 17182.68TRUE00
2024-08-1612.50PUT0 0280.54TRUE00
2024-11-152.51.18CALL50 91118.72TRUE1.180
2024-11-1550.7CALL4 79134FALSE0.70
2024-11-157.50.4CALL3 86130.3FALSE00
2024-11-15100.27CALL20 50131.88FALSE-0.03-0.1
2024-11-152.50.7PUT0 59131.28FALSE00
2024-11-1552.35PUT0 22124.39TRUE00
2024-11-157.50PUT0 0122.59TRUE00
2024-11-15100PUT0 0178.56TRUE00

Latest PDSB Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST8$3.05
Jun 13, 2022 7:59 PM EST1$3.05
Jun 13, 2022 7:59 PM EST5$3.05
Jun 13, 2022 7:59 PM EST10$3.05
Jun 13, 2022 7:59 PM EST1$3.05

PDS Biotechnology Corporation (PDSB) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120015119/0001140361-20-015119-index.htm
2019-08-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1472091/000000000019012484/0000000000-19-012484-index.htm
2019-12-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1472091/000000000019016765/0000000000-19-016765-index.htm
2020-07-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1472091/000000000020006807/0000000000-20-006807-index.htm
2020-02-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1472091/000101103420000015/0001011034-20-000015-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011903/0001127602-19-011903-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011907/0001127602-19-011907-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011911/0001127602-19-011911-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011917/0001127602-19-011917-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011924/0001127602-19-011924-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011927/0001127602-19-011927-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011932/0001127602-19-011932-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011935/0001127602-19-011935-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011939/0001127602-19-011939-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011941/0001127602-19-011941-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219011943/0001127602-19-011943-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219021141/0001127602-19-021141-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219021146/0001127602-19-021146-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219021152/0001127602-19-021152-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219023217/0001127602-19-023217-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219023219/0001127602-19-023219-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219023223/0001127602-19-023223-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219023235/0001127602-19-023235-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219023240/0001127602-19-023240-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000112760219023251/0001127602-19-023251-index.htm
2019-01-25S-4/ARegistration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119001609/0001140361-19-001609-index.htm
2019-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119001981/0001140361-19-001981-index.htm
2019-01-30425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119001982/0001140361-19-001982-index.htm
2019-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119002427/0001140361-19-002427-index.htm
2019-02-04425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119002428/0001140361-19-002428-index.htm
2019-02-15424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1472091/000114036119003307/0001140361-19-003307-index.htm
2019-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119003588/0001140361-19-003588-index.htm
2019-02-21425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119003633/0001140361-19-003633-index.htm
2019-02-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1472091/000114036119003636/0001140361-19-003636-index.htm
2019-02-22S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119003707/0001140361-19-003707-index.htm
2019-02-25425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119003784/0001140361-19-003784-index.htm
2019-03-04425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119004364/0001140361-19-004364-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119004367/0001140361-19-004367-index.htm
2019-03-04425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119004368/0001140361-19-004368-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119004622/0001140361-19-004622-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119005051/0001140361-19-005051-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119005071/0001140361-19-005071-index.htm
2019-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119005555/0001140361-19-005555-index.htm
2019-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119005559/0001140361-19-005559-index.htm
2019-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119005561/0001140361-19-005561-index.htm
2019-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119005565/0001140361-19-005565-index.htm
2019-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119005567/0001140361-19-005567-index.htm
2019-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119005569/0001140361-19-005569-index.htm
2019-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119005750/0001140361-19-005750-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119006714/0001140361-19-006714-index.htm
2019-04-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119006877/0001140361-19-006877-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119007015/0001140361-19-007015-index.htm
2019-04-308-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119008024/0001140361-19-008024-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119009103/0001140361-19-009103-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1472091/000114036119009128/0001140361-19-009128-index.htm
2019-05-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119009807/0001140361-19-009807-index.htm
2019-06-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119010389/0001140361-19-010389-index.htm
2019-06-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119010390/0001140361-19-010390-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119011300/0001140361-19-011300-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119013661/0001140361-19-013661-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119013921/0001140361-19-013921-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1472091/000114036119013922/0001140361-19-013922-index.htm
2019-08-02S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1472091/000114036119014132/0001140361-19-014132-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119014222/0001140361-19-014222-index.htm
2019-08-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119015162/0001140361-19-015162-index.htm
2019-08-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036119015386/0001140361-19-015386-index.htm
2019-08-20S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1472091/000114036119015390/0001140361-19-015390-index.htm
2019-08-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036119015612/0001140361-19-015612-index.htm
2019-08-29424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1472091/000114036119015796/0001140361-19-015796-index.htm
2019-09-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119016975/0001140361-19-016975-index.htm
2019-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119017154/0001140361-19-017154-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119017653/0001140361-19-017653-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119017903/0001140361-19-017903-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119018860/0001140361-19-018860-index.htm
2019-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119019291/0001140361-19-019291-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119019940/0001140361-19-019940-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119019966/0001140361-19-019966-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1472091/000114036119019968/0001140361-19-019968-index.htm
2019-11-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1472091/000114036119020567/0001140361-19-020567-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119021350/0001140361-19-021350-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119021875/0001140361-19-021875-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119022378/0001140361-19-022378-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119022379/0001140361-19-022379-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036119022521/0001140361-19-022521-index.htm
2019-12-17S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1472091/000114036119022730/0001140361-19-022730-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120000709/0001140361-20-000709-index.htm
2020-01-31S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1472091/000114036120001970/0001140361-20-001970-index.htm
2020-01-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120001974/0001140361-20-001974-index.htm
2020-01-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120001979/0001140361-20-001979-index.htm
2020-02-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002261/0001140361-20-002261-index.htm
2020-02-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002262/0001140361-20-002262-index.htm
2020-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002366/0001140361-20-002366-index.htm
2020-02-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002368/0001140361-20-002368-index.htm
2020-02-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002489/0001140361-20-002489-index.htm
2020-02-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002491/0001140361-20-002491-index.htm
2020-02-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002594/0001140361-20-002594-index.htm
2020-02-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002595/0001140361-20-002595-index.htm
2020-02-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002732/0001140361-20-002732-index.htm
2020-02-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002734/0001140361-20-002734-index.htm
2020-02-11FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120002751/0001140361-20-002751-index.htm
2020-02-12424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1472091/000114036120002968/0001140361-20-002968-index.htm
2020-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120003371/0001140361-20-003371-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120003644/0001140361-20-003644-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120003645/0001140361-20-003645-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120003646/0001140361-20-003646-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120003647/0001140361-20-003647-index.htm
2020-02-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120003906/0001140361-20-003906-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120003908/0001140361-20-003908-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120004280/0001140361-20-004280-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120006583/0001140361-20-006583-index.htm
2020-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120006833/0001140361-20-006833-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120007227/0001140361-20-007227-index.htm
2020-03-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1472091/000114036120007252/0001140361-20-007252-index.htm
2020-04-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120008499/0001140361-20-008499-index.htm
2020-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120008509/0001140361-20-008509-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120008514/0001140361-20-008514-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120009059/0001140361-20-009059-index.htm
2020-04-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120009299/0001140361-20-009299-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120010158/0001140361-20-010158-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1472091/000114036120010164/0001140361-20-010164-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120011495/0001140361-20-011495-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1472091/000114036120011497/0001140361-20-011497-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120013061/0001140361-20-013061-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120013418/0001140361-20-013418-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014088/0001140361-20-014088-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014627/0001140361-20-014627-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014759/0001140361-20-014759-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014762/0001140361-20-014762-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014764/0001140361-20-014764-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014765/0001140361-20-014765-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014767/0001140361-20-014767-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014769/0001140361-20-014769-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014772/0001140361-20-014772-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014773/0001140361-20-014773-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120014781/0001140361-20-014781-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120015119/0001140361-20-015119-index.htm
2020-07-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120015434/0001140361-20-015434-index.htm
2020-07-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120015968/0001140361-20-015968-index.htm
2020-07-22S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1472091/000114036120016532/0001140361-20-016532-index.htm
2020-07-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1472091/000114036120016956/0001140361-20-016956-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120017195/0001140361-20-017195-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120017978/0001140361-20-017978-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1472091/000114036120017981/0001140361-20-017981-index.htm
2020-08-12424B2Prospectus [Rule 424(b)(2)]https://www.sec.gov/Archives/edgar/data/1472091/000114036120018192/0001140361-20-018192-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120018293/0001140361-20-018293-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120018338/0001140361-20-018338-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1472091/000114036120018339/0001140361-20-018339-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120020494/0001140361-20-020494-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120024114/0001140361-20-024114-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000114036120024679/0001140361-20-024679-index.htm
2020-11-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120024924/0001140361-20-024924-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1472091/000114036120024925/0001140361-20-024925-index.htm
2019-03-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1472091/000114420419016355/0001144204-19-016355-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1472091/000119312519037289/0001193125-19-037289-index.htm
2019-03-25SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1472091/000119312519085311/0001193125-19-085311-index.htm
2020-03-02SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1472091/000119312520058987/0001193125-20-058987-index.htm
2020-08-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1472091/000119312520227049/0001193125-20-227049-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1472091/000127417319000014/0001274173-19-000014-index.htm
2020-01-17S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1472091/000156761920001206/0001567619-20-001206-index.htm
2020-01-17FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1472091/000156761920001210/0001567619-20-001210-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1472091/000156761920010699/0001567619-20-010699-index.htm
2019-08-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1472091/999999999519001982/9999999995-19-001982-index.htm
2020-02-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1472091/999999999520000316/9999999995-20-000316-index.htm
2020-07-31EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1472091/999999999520001995/9999999995-20-001995-index.htm
2019-02-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1472091/999999999719000331/9999999997-19-000331-index.htm

PDS Biotechnology Corporation (PDSB) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PDS Biotechnology Corporation (PDSB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2761%
Institutional Ownership: 1481%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-15ISAAC BLECHDirectorBuy10,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011917/0001127602-19-011917-index.htm
2019-03-15Liam RatcliffeDirectorBuy10,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011935/0001127602-19-011935-index.htm
2019-03-15Rosemary A CraneDirectorBuy10,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011907/0001127602-19-011907-index.htm
2019-03-15Brian A LeuthnerPresident and CEOBuy169,032.00239,268.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011924/0001127602-19-011924-index.htm
2019-03-15JAMES J LOUGHLINDirectorBuy10,000.0026,625.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011927/0001127602-19-011927-index.htm
2020-02-14Gregory Gene FreitagDirectorBuy38,400.001.3049,920.0040,271.00https://www.sec.gov/Archives/edgar/data/1472091/000114036120003647/0001140361-20-003647-index.htm
2020-02-14Andrew SaikChief Financial OfficerBuy38,400.001.3049,920.0042,549.00https://www.sec.gov/Archives/edgar/data/1472091/000114036120003645/0001140361-20-003645-index.htm
2020-02-14RICHARD SYKESDirectorBuy384,615.001.30499,999.50445,108.00https://www.sec.gov/Archives/edgar/data/1472091/000114036120003646/0001140361-20-003646-index.htm
2019-03-15Robert J. SpiegelDirectorBuy10,000.0048,661.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011941/0001127602-19-011941-index.htm
2020-02-14Steve C GloverDirectorBuy38,400.001.3049,920.0057,908.00https://www.sec.gov/Archives/edgar/data/1472091/000114036120003644/0001140361-20-003644-index.htm
2019-03-15R. Loch MacdonaldDirectorBuy10,000.00580,602.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011943/0001127602-19-011943-index.htm
2019-03-15W BRADFORD MIDDLEKAUFFSenior VP, GC and SecretaryBuy49,766.0059,766.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011932/0001127602-19-011932-index.htm
2019-03-15SOL J BARERDirectorBuy20,000.00678,075.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011903/0001127602-19-011903-index.htm
2019-03-15Andrew SaikChief Financial OfficerBuy82,999.0082,999.00https://www.sec.gov/Archives/edgar/data/1472091/000112760219011939/0001127602-19-011939-index.htm